Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 8 (August)

1. The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
   Br J Cancer, 97(3): 302-7. [Abstract] [Full-text]
2. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
   Ther Drug Monit, 29(4): 447-51. [Abstract] [Full-text]
3. ASTRO's 2007 Core Physics Curriculum for Radiation Oncology Residents.
   Int J Radiat Oncol Biol Phys, 68(5): 1276-88. [Abstract] [Full-text]
4. Current Status of the Infrastructure and Characteristics of Radiation Oncology in Korea.
   Jpn J Clin Oncol. [Abstract] [Full-text]
5. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
   Blood, 110(4): 1105-11. [Abstract] [Full-text]
6. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.
   Arch Pediatr Adolesc Med, 161(8): 798-806. [Abstract] [Full-text]
7. Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology Group.
   Cancer, 110(4): 759-63. [Abstract] [Full-text]
8. Ontario doctors' attitudes toward and use of clinical practice guidelines in oncology.
   J Eval Clin Pract, 13(4): 607-15. [Abstract] [Full-text]
9. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
   J Clin Oncol, 25(23): 3482-7. [Abstract] [Full-text]
10. Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004.
    Cancer Sci, 98(9): 1350-7. [Abstract] [Full-text]
11. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations.
    Ann Oncol, 18(8): 1314-21. [Abstract] [Full-text]
12. Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature.
    Breast Cancer Res Treat, 105(1): 81-5. [Abstract] [Full-text]
13. Twenty years of therapeutic touch in a Canadian cancer agency: lessons learned from a case study of integrative oncology practice.
    Support Care Cancer, 15(8): 993-8. [Abstract] [Full-text]
14. Predicting the active doses in humans from animal studies: A novel approach in oncology.
    Eur J Cancer, 43(12): 1862-8. [Abstract] [Full-text]
15. Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
    Int J Radiat Oncol Biol Phys, 69(1): 79-87. [Abstract] [Full-text]
16. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    J Clin Oncol, 25(24): 3657-63. [Abstract] [Full-text]
17. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 25(24): 3621-7. [Abstract] [Full-text]
18. PET and PET/CT in pediatric oncology.
    Semin Nucl Med, 37(5): 316-31. [Abstract] [Full-text]
19. Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Blood, 110(5): 1429-38. [Abstract] [Full-text]
20. A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.
    Pediatr Blood Cancer, 49(5): 661-5. [Abstract] [Full-text]
21. Evidence-based radiation oncology: Definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer.
    Radiother Oncol, 84(2): 197-215. [Abstract] [Full-text]
22. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.
    Radiother Oncol, 84(2): 121-7. [Abstract] [Full-text]
23. A model of chemotherapy education for novice oncology nurses that supports a culture of safety.
    Clin J Oncol Nurs, 11(4): 545-51. [Abstract] [Full-text]
24. A review of anemia management in the oncology setting: a focus on implementing standing orders.
    Clin J Oncol Nurs, 11(4): 534-9. [Abstract] [Full-text]
25. Inpatient diabetes mellitus in the oncology setting.
    Clin J Oncol Nurs, 11(4): 489-92. [Abstract] [Full-text]
26. Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice.
    Support Care Cancer, 15(9): 1075-85. [Abstract] [Full-text]
27. The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients.
    Eur J Clin Nutr. [Abstract] [Full-text]
28. Pediatric oncology.
    Curr Opin Chem Biol, 11(4): 424-32. [Abstract] [Full-text]
29. Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis.
    Gynecol Oncol, 106(3): 439-45. [Abstract] [Full-text]
30. A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
    Gynecol Oncol, 106(3): 596-603. [Abstract] [Full-text]
31. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
    J Clin Oncol, 25(25): 3991-4008. [Abstract] [Full-text]
32. Pyoderma gangraenosum, a rare, but potentially fatal complication in paediatric oncology patients.
    Klin Padiatr, 219(5): 296-9. [Abstract] [Full-text]
33. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.
    Gynecol Oncol, 106(3): 521-5. [Abstract] [Full-text]
34. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Am J Clin Oncol, 30(4): 428-31. [Abstract] [Full-text]
35. Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.
    Am J Clin Oncol, 30(4): 406-19. [Abstract] [Full-text]
36. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    J Clin Oncol, 25(25): 3971-7. [Abstract] [Full-text]
37. The development of audio-visual materials to prepare patients for medical procedures: an oncology application.
    Eur J Cancer Care (Engl), 16(5): 417-23. [Abstract] [Full-text]
38. Ethics-in-oncology forums.
    J Cancer Educ, 22(3): 159-64. [Abstract] [Full-text]
39. Development of communication skills workshop for oncology advanced practice nursing students.
    J Cancer Educ, 22(3): 149-53. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.